SCHEMBL6899692

SCHEMBL6899692

CC(C)(CCOCCOCCC(C)(C)COP(N)(=O)OCC(C)(C)CCOCCOCCC(C)(C)COP(N)(=O)O)COP(N)(=O)O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256378 0.95 GRM4 (0.35) GRM4
SCHEMBL6258025 0.89 CYP3A4 (0.33) GRM4
SCHEMBL6895588 0.88 SMPD1 (0.33)
SCHEMBL6802544 0.88 CYP3A4 (0.31)
SCHEMBL6894913 0.85
SCHEMBL6255716 0.82 GRM4 (0.32) GRM4
SCHEMBL6256433 0.82 SMPD1 (0.36) GRM4
SCHEMBL6254526 0.82 CYP3A4 (0.33) GRM4
SCHEMBL6257990 0.80 TPI1 (0.36) GRM4
SCHEMBL7173545 0.79 GRM4 (0.32) GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004529069-A 2004-09-24 JP claimed
EP-1351916-A2 ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-10-15 EP claimed
WO-2002030863-A2 ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed